ENTA (Enanta Pharmaceuticals, Inc.) Stock Market Reviews

crown

search

Read and share opinions on ENTA (Enanta Pharmaceuticals, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock ma

ENTA

Enanta Pharmaceuticals, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences
Nov 4, 2025
Enanta Pharmaceuticals Presents New Data for Zelicapavir, its N-Protein Inhibitor, and EDP-323, its L-Protein Inhibitor, Both in Development for the Treatment of Respiratory Syncytial Virus (RSV) at IDWeek™ 2025
Oct 20, 2025
Enanta Pharmaceuticals to Present Data for Zelicapavir and EDP-323, Two Candidates in Development for the Treatment of Respiratory Syncytial Virus (RSV) at IDWeek™ 2025
Oct 7, 2025
Enanta Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 2, 2025
Enanta Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
Oct 1, 2025
Enanta Pharmaceuticals Announces Proposed Public Offering of Common Stock
Sep 30, 2025
Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults
Sep 29, 2025
Enanta Pharmaceuticals Says Zelicapavir Misses Phase 2 Primary Endpoint, But Shows RSV Improvement
Sep 29, 2025
Enanta Pharmaceuticals Reports Positive Topline Results from its Phase 2b Study of Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults
Sep 29, 2025
Enanta Pharmaceuticals to Present Topline Results from its Phase 2b Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults
Sep 26, 2025
Enanta Pharmaceuticals Announces the Passing of its Beloved and Respected Longtime Chief Financial and Administrative Officer Paul J. Mellett Jr.
Sep 3, 2025
Does Enanta’s EU Lawsuit Over Paxlovid Shift the Bull Case for Pfizer (PFE)?
Aug 28, 2025
Enanta Pharmaceuticals to Participate in September Investor Conferences
Aug 21, 2025

Reviews